P53 Suppressor Gene Tissue Microarray-based Protein Expression Analysis in Meningiomas

Dimitrios Roukas1, Anastasios Kouzoupis2, Despoina Spyropoulou3

  • 1Department of Psychiatry, 417 VA (NIMTS) Hospital, Athens, Greece.

In Vivo (Athens, Greece)
|September 13, 2022
PubMed
Abstract

Insights

p53 overexpression is common in meningiomas, a type of brain tumor. High p53 levels correlate with aggressive tumor behavior and higher recurrence rates, particularly in atypical and anaplastic subtypes.

Area of Science:

  • Neuro-oncology
  • Molecular pathology
  • Cancer genetics

Background:

  • Meningiomas are the most common primary intracranial CNS tumors in adults.
  • Tumorigenesis involves oncogene over-activation and tumor suppressor gene silencing.
  • The role of p53 suppressor gene expression in meningioma behavior requires further investigation.

Purpose of the Study:

  • To investigate the impact of p53 suppressor gene expression on meningioma clinic-pathological features.
  • To analyze p53 protein expression levels in various meningioma subtypes.
  • To correlate p53 expression with tumor aggressiveness and mitotic activity.

Main Methods:

  • Immunohistochemistry assay on tissue microarray cores from 50 meningiomas.
  • Digital image analysis for quantitative assessment of p53 protein expression.
  • Inclusion of a diverse range of histopathological subtypes.

Main Results:

  • p53 protein overexpression (high staining) observed in 54% of cases (27/50).
  • p53 overexpression significantly correlated with increased mitotic index (p=0.001).
  • Atypical and anaplastic meningiomas showed the highest p53 expression rates (p=0.001).

Conclusions:

  • p53 overexpression is prevalent across various meningioma subtypes.
  • High p53 expression is linked to aggressive biological behavior and increased mitotic rates.
  • Elevated p53 levels are particularly associated with aggressive atypical/anaplastic meningiomas and their high recurrence rates.